Kerstin Hamberg Levedahl

Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry

Niedoszytko, Marek; Gorska, Aleksandra; Brockow, Knut; Bonadonna, Patrizia et al.

Ingår i Allergy. European Journal of Allergy and Clinical Immunology, s. 2470-2481, 2024

• DOI för Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Ingår i Journal of Molecular Diagnostics, s. 792-804, 2024

• DOI för Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
• Ladda ner fulltext (pdf) av Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Struyf, Nona; Österroos, Albin; Vesterlund, Mattias; Arnroth, Cornelia et al.

Ingår i npj Precision Oncology, 2024

• DOI för Delineating functional and molecular impact of ex vivo sample handling in precision medicine
• Ladda ner fulltext (pdf) av Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

Ginman, Beatrice; Pahnke, Simon; Freyhult, Eva; Hoffman, Tove et al.

Ingår i Acta Oncologica, s. 1707-1715, 2023

• DOI för Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2
• Ladda ner fulltext (pdf) av Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis

Hamberg Levedahl, Kerstin; Nilsson, Annika; Johansson, Birgitta; Hedström, Mariann

Ingår i Primary Health Care Research and Development, 2022

• DOI för How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis
• Ladda ner fulltext (pdf) av How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis

Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry

Niedoszytko, Marek; Gorska, Aleksandra; Brockow, Knut; Bonadonna, Patrizia et al.

Ingår i Allergy. European Journal of Allergy and Clinical Immunology, s. 2470-2481, 2024

• DOI för Prevalence of hypersensitivity reactions in various forms of mastocytosis: A pilot study of 2485 adult patients with mastocytosis collected in the ECNM registry

Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Iribarren, Cristina; Levedahl, Kerstin; Atanasoai, Ionut; Mattsson, Mattias et al.

Ingår i Journal of Molecular Diagnostics, s. 792-804, 2024

• DOI för Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis
• Ladda ner fulltext (pdf) av Plasma Protein Profiling to Discern Indolent from Advanced Systemic Mastocytosis

Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Struyf, Nona; Österroos, Albin; Vesterlund, Mattias; Arnroth, Cornelia et al.

Ingår i npj Precision Oncology, 2024

• DOI för Delineating functional and molecular impact of ex vivo sample handling in precision medicine
• Ladda ner fulltext (pdf) av Delineating functional and molecular impact of ex vivo sample handling in precision medicine

Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

Ginman, Beatrice; Pahnke, Simon; Freyhult, Eva; Hoffman, Tove et al.

Ingår i Acta Oncologica, s. 1707-1715, 2023

• DOI för Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2
• Ladda ner fulltext (pdf) av Strict self-isolation did not protect Swedish cancer patients on active treatment from the risk of becoming seropositive for SARS-CoV-2

How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis

Hamberg Levedahl, Kerstin; Nilsson, Annika; Johansson, Birgitta; Hedström, Mariann

Ingår i Primary Health Care Research and Development, 2022

• DOI för How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis
• Ladda ner fulltext (pdf) av How persons with systemic mastocytosis describe the time between symptom onset and receiving diagnosis

Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway

Lampinen, Maria; Hagforsen, Eva; Weström, Simone; Bergström, Anna et al.

Ingår i Experimental dermatology, s. 1729-1740, 2022

• DOI för Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway
• Ladda ner fulltext (pdf) av Mefloquine causes selective mast cell apoptosis in cutaneous mastocytosis lesions by a secretory granule-mediated pathway

International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia

Oerlemans, Simone; Efficace, Fabio; Kieffer, Jacobien M.; Kyriakou, Charalampia et al.

Ingår i British Journal of Haematology, s. 431-441, 2022

• DOI för International validation of the EORTC QLQ-CLL17 questionnaire for assessment of health-related quality of life for patients with chronic lymphocytic leukaemia

Living with systemic mastocytosis: Balancing between vulnerability and resilience: A qualitative study

Levedahl, Kerstin; Nilsson, Annika; Ungerstedt, Johanna; Hedström, Mariann

Ingår i European Journal of Oncology Nursing, 2022

• DOI för Living with systemic mastocytosis: Balancing between vulnerability and resilience: A qualitative study
• Ladda ner fulltext (pdf) av Living with systemic mastocytosis: Balancing between vulnerability and resilience: A qualitative study

Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

Eltahir, mohmo394; Fletcher, E.; Dynesius, L.; Jarblad, J. L. et al.

Ingår i International Immunopharmacology, 2021

• DOI för Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients
• Ladda ner fulltext (pdf) av Profiling of donor-specific immune effector signatures in response to rituximab in a human whole blood loop assay using blood from CLL patients

CD203c distinguishes the erythroid and mast cell-basophil differentiation trajectories among human Fc epsilon RI+ bone marrow progenitors

Grootens, Jennine; Ungerstedt, Johanna S.; Wu, Chenyan; Levedahl, Kerstin et al.

Ingår i Allergy. European Journal of Allergy and Clinical Immunology, s. 211-214, 2020

• DOI för CD203c distinguishes the erythroid and mast cell-basophil differentiation trajectories among human Fc epsilon RI+ bone marrow progenitors
• Ladda ner fulltext (pdf) av CD203c distinguishes the erythroid and mast cell-basophil differentiation trajectories among human Fc epsilon RI+ bone marrow progenitors

AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays

Kumar, Jagarlamudi Kiran; Holmgren, Sofia; Hamberg Levedahl, Kerstin; Höglund, Martin et al.

Ingår i BioTechniques, s. 335-342, 2020

• DOI för AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays
• Ladda ner fulltext (pdf) av AroCell TK 210 ELISA for determination of TK1 protein: age-related reference ranges and comparison with other TK1 assays

Clonal evolution patterns in high-risk chronic lymphocytic leukemia treated with ibrutinib

Mattsson, Mattias; Ljungström, Viktor; Djureinovic, Tatjana; Mansouri, Larry et al.